ViaLase develops femtosecond laser systems for ophthalmic procedures.
Founded in 2019 and based in Aliso Viejo, US, ViaLase develops laser technology for refractive, cataract and glaucoma procedures. Its system combines femtosecond lasers with gonio imaging to create drainage channels through the trabecular meshwork. In April 2024, the company raised USD 40 million in Series C funding from Venture Investors Health Fund, Arboretum Ventures, Falcon Vision, KKR and Flying L Partners. The funds were intended to support clinical, regulatory and commercial milestones.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in